[1]饶 军,程贤高,李晓春,等.布地奈德联合肺表面活性物质气管内注入防治早产儿支气管肺发育不良的效果[J].医学信息,2020,33(23):147-149.[doi:10.3969/j.issn.1006-1959.2020.23.043]
　RAO Jun,CHENG Xian-gao,LI Xiao-chun,et al.Effect of Intratracheal Injection of Budesonide Combined with Pulmonary Surfactant in the Prevention and Treatment of Bronchopulmonary Dysplasia in Premature Infants[J].Medical Information,2020,33(23):147-149.[doi:10.3969/j.issn.1006-1959.2020.23.043]
点击复制

布地奈德联合肺表面活性物质气管内注入防治早产儿支气管肺发育不良的效果()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
33卷
期数:
2020年23期
页码:
147-149
栏目:
药物与临床
出版日期:
2020-12-01

文章信息/Info

Title:
Effect of Intratracheal Injection of Budesonide Combined with Pulmonary Surfactant in the Prevention and Treatment of Bronchopulmonary Dysplasia in Premature Infants
文章编号:
1006-1959（2020）23-0147-03
作者:
饶 军; 程贤高; 李晓春; 等
（安徽医科大学附属安庆医院新生儿科，安徽 安庆 246000）
Author(s):
RAO Jun; CHENG Xian-gao; LI Xiao-chun; et al
(Department of Neonatology,Anqing Hospital Affiliated toAnhui Medical University,Anqing 246000,Anhui,China)
关键词:
早产儿; 支气管肺发育不良; 布地奈德; 肺表面活性物质
Keywords:
Premature infant; Bronchopulmonary dysplasia; Budesonide; Pulmonary surfactant
分类号:
R722.6
DOI:
10.3969/j.issn.1006-1959.2020.23.043
文献标志码:
A
摘要:
目的 探讨布地奈德联合肺表面活性物质（PS）与单独应用PS对支气管肺发育不良（BPD）的影响。方法 选取2018年8月~2020年6月我院新生儿科收治的64例新生儿呼吸窘迫综合征早产儿作为研究对象，以入院时间顺序随机分成观察组和对照组，各32例。对照组给予PS气管（气管插管或LISA管）内滴入，观察组给予布地奈德联合PS气管（气管插管或LISA管）内滴入，比较两组用药前后动脉血气指标、呼吸机应用时间、吸氧时间、住院时间、BPD发生率、PS重复给药率及并发症发生率。结果 给药后，两组pH值、PaO2、PaO2/FiO2高于给药前，PaCO2低于给药前，且观察组pH值、PaO2、PaO2/FiO2高于对照组，PaCO2低于对照组，差异有统计学意义（P＜0.05）；观察组呼吸机应用时间、吸氧时间、住院时间短于对照组，差异有统计学意义（P＜0.05）；观察组BPD发生率、PS重复使用率低于对照组（15.63% vs 37.50%）、（3.13% vs 21.88%），差异有统计学意义（P＜0.05）；两组并发症发生率比较，差异无统计学意义（P＞0.05）。结论 对早产儿气管插管或LISA管下滴入布地奈德联合PS治疗，可改善患儿肺功能指标，抑制炎症反应，有效防止早产儿支气管肺发育不良发生几率，不增加其他并发症的风险，且可缩短呼吸机应用时间、总吸氧时间、住院时间，并降低PS的重复使用率。
Abstract:
Objective To investigate the effects of budesonide combined with pulmonary surfactant(PS) and PS alone on bronchopulmonary dysplasia(BPD).Methods From August 2018 to June 2020, 64 premature infants diagnosed with neonatal respiratory distress syndrome were selected from neonatology department of our Hospital.The patients were randomly divided into the observation group and the control group according to the order of admission,32 cases in each group.Observation group received budesonide combined with PS trachea (tracheal intubation or LISA tube) drip,the control group only received PS trachea (tracheal intubation or LISA tube) drip.To analyze the arterial blood gas indexes of the two groups before and after drug administration and compare the ventilator use time, oxygen intake time, hospital stay time, BPD incidence, PS repetition rate and complication rate between the two groups.Results After administration, the pH value, PaO2, PaO2/FiO2 of the two groups were higher than before administration, PaCO2 was lower than before administration, and the pH value, PaO2, PaO2/FiO2 of the observation group were higher than those of the control group, and PaCO2 was lower than the control group,the difference was statistically significant (P<0.05); the observation group’s ventilator application time, oxygen inhalation time, and hospital stay were shorter than those of the control group,the difference was statistically significant (P<0.05); the observation group’s incidence of BPD and PS repeated use rate was lower than the control group (15.63% vs 37.50%), (3.13% vs 21.88%), the difference was statistically significant (P<0.05); the complication rate between the two groups was not statistically significant (P>0.05).Conclusion Intratracheal intubation or LISA tube infusion of budesonide combined with PS therapy in premature infants can improve lung function indicators, inhibit inflammation, and effectively prevent the incidence of bronchopulmonary dysplasia in premature infants without increasing other complications. Risk, shorten the ventilator application time, total oxygen inhalation time, hospital stay, and reduce the repetitive use rate of PS.

参考文献/References:

[1]早产儿支气管肺发育不良调查协作组.早产儿支气管肺发育不良发生率及高危因素的多中心回顾调查分析[J].中华儿科杂志,2011,49(9):655-662. [2]江苏省新生儿重症监护病房母乳质量改进临床研究协作组.多中心回顾性分析极低及超低出生体重儿支气管肺发育不良的临床特点及高危因素[J].中华儿科杂志,2019,57(1):33-39. [3]Bassler D.Inhalation or Instillation of Steroids for the Prevention of Bronchopulmonary Dysplasia[J].Neonatology,2015,107(4):358. [4]Patel RM.Does early treatment with inhaled budesonide prevent death or bronchopulmonary dysplasia in extremely preterm infants?[J].Acta Paediatr,2017,106(4):683. [5]陈琼华,郑敬阳,张圳杰,等.婴幼儿反复喘息136例病因分析[J].福建医药杂志,2019,41(6):12-15. [6]黎丹华,周华涛,林娓娴,等.支气管肺发育不良患儿呼吸系统预后及肺功能评估的研究[J].国际儿科学杂志,2020,47(3):217-220. [7]Cardoen F,Vermeulen F,Proesmans M,et al.Lung function evolution in children with old and new type bronchopulmonary dysplasia：a retrospective cohort analysis[J].Eur J Pediatr,2019,178(12):1859-1866. [8]王丹丹,孙健伟,高峰,等.早产儿支气管肺发育不良的病因及治疗进展[J].现代临床医学,2020,46(1):69-72. [9]朱逸馨,张华.早产儿新型支气管肺发育不良研究进展[J].中国当代医药,2018,25(8):27-30. [10]丁悦,唐丽君,黄为民.早产儿支气管肺发育不良的诊治新进展[J].实用儿科临床杂志,2012,27(2):141-146. [11]Halliday HL,Ehrenkranz RA,Doyle LW.Early postnatal(<96 hours)corticosteroids for preventing chronic lung disease in preterm infants[J].Cochrane Database Syst Rev,2003(1):CD001146. [12]Halliday HL,Ehrenkranz RA,Doyle LW.Early(<8 days)postnatal corticosteroids for preventing chronic lung disease in preterm infants[J].Cochrane Database Syst Rev,2010(1):CD001146. [13]余静,喻婷婷.不同剂型布地奈德联合肺泡表面活性物质治疗新生儿呼吸窘迫综合征的临床分析[J].中华肺部疾病杂志(电子版),2018,11(4):416-420. [14]黄进洁,闫玉琴,李志光,等.布地奈德防治早产儿支气管肺发育不良的临床研究[J].中国临床药理学杂志,2020,36(4):390-392. [15]Yeh TF,Chen CM,Wu SY,et al.Intra-tracheal Administration of Budesonide/Surfactant to Prevent Bronchopulmonary Dysplasia[J].Am J Respir Crit Care Med,2016,193(1):86-95.

相似文献/References:

[1]石福建.N-CPAP模式和NIPPV对呼吸窘迫综合征早产儿心功能的影响分析[J].医学信息,2018,31(02):91.[doi:10.3969/j.issn.1006-1959.2018.02.031]
　SHI Fu-jian.Effect of N-CPAP Mode and NPIPPV on Cardiac Function in Preterm Infants with Respiratory Distress Syndrome[J].Medical Information,2018,31(23):91.[doi:10.3969/j.issn.1006-1959.2018.02.031]
[2]刘亿荣,吴开锋,曾春英,等.早产儿肠道喂养方式对住院期间变应性疾病的影响[J].医学信息,2018,31(02):105.[doi:10.3969/j.issn.1006-1959.2018.02.037]
　LIU Yi-Rong,WU Kai-Feng,ZENG Chun-Ying,et al.Effects of Gut Feeding on Preterm Infant Allergic Diseases during Hospitalization[J].Medical Information,2018,31(23):105.[doi:10.3969/j.issn.1006-1959.2018.02.037]
[3]赵 菁.脐带不同结扎方式对新生儿影响的研究进展[J].医学信息,2018,31(04):53.[doi:10.3969/j.issn.1006-1959.2018.04.017]
　ZHAO Jing.Research Progress on the Influence of Different Umbilical Cord Ligation on Neonates[J].Medical Information,2018,31(23):53.[doi:10.3969/j.issn.1006-1959.2018.04.017]
[4]董显燕,高李华.BNP及NT-proBN诊断早产儿动脉导管未闭临床分析[J].医学信息,2019,32(12):70.[doi:10.3969/j.issn.1006-1959.2019.12.022]
　DONG Xian-yan,GAO Li-hua.Clinical Analysis of BNP and NT-proBN in the Diagnosis of Patent Ductus Arteriosus in Premature Infants[J].Medical Information,2019,32(23):70.[doi:10.3969/j.issn.1006-1959.2019.12.022]
[5]龙小红.枸橼酸咖啡因对早产儿原发性呼吸暂停及相关并发症的影响[J].医学信息,2019,32(22):130.[doi:10.3969/j.issn.1006-1959.2019.22.043]
　LONG Xiao-hong.Effect of Caffeine Citrate on Primary Apnea and Related Complications in Premature Infants[J].Medical Information,2019,32(23):130.[doi:10.3969/j.issn.1006-1959.2019.22.043]
[6]于 波.静脉注射丙种球蛋白治疗早产儿肺炎临床疗效[J].医学信息,2020,33(04):149.[doi:10.3969/j.issn.1006-1959.2020.04.048]
　YU Bo.Clinical Efficacy of Intravenous Gamma Globulin in Premature Infants with Pneumonia[J].Medical Information,2020,33(23):149.[doi:10.3969/j.issn.1006-1959.2020.04.048]
[7]项拉丽,潘丽慧,许玲雪.俯卧位经鼻持续气道正压通气在早产儿呼吸窘迫中的应用效果[J].医学信息,2021,34(21):184.[doi:10.3969/j.issn.1006-1959.2021.21.053]
　XIANG La-li,PAN Li-hui,XU Ling-xue.Application Effect of Nasal Continuous Positive Airway Pressure Ventilation on Prone Position in Premature Infants with Respiratory Distress[J].Medical Information,2021,34(23):184.[doi:10.3969/j.issn.1006-1959.2021.21.053]
[8]张 敏,蒙好好,廖爱玲,等.母乳库母乳喂养对早产儿生长发育的影响[J].医学信息,2020,33(08):176.[doi:10.3969/j.issn.1006-1959.2020.08.060]
　ZHANG Min,MENG Hao-hao,LIAO Ai-ling,et al.Effect of Breastfeeding in Breast Milk Bank on Growth and Development of Premature Infants[J].Medical Information,2020,33(23):176.[doi:10.3969/j.issn.1006-1959.2020.08.060]
[9]魏 颖,罗 芳.CPAP联合不同时间应用肺表面活性物质对早产呼吸窘迫综合征患儿预后的影响[J].医学信息,2022,35(19):92.[doi:10.3969/j.issn.1006-1959.2022.19.025]
　WEI Ying,LUO Fang.Effect of CPAP Combined with Different Time Application of Pulmonary Surfactant on Prognosis of Premature Infants with Respiratory Distress Syndrome[J].Medical Information,2022,35(23):92.[doi:10.3969/j.issn.1006-1959.2022.19.025]
[10]王永明,马利勇,马 丽,等.INSURE技术后行有创机械通气治疗呼吸评分≥8分早产儿RDS的疗效[J].医学信息,2022,35(19):106.[doi:10.3969/j.issn.1006-1959.2022.19.029]
　WANG Yong-ming,MA Li-yong,MA Li,et al.The Efficacy of Invasive Mechanical Ventilation After INSURE Technique in the Treatment of RDS in Premature Infants with Respiratory Score ≥8 Scores[J].Medical Information,2022,35(23):106.[doi:10.3969/j.issn.1006-1959.2022.19.029]
[11]沙春娜,张海鸿.枸橼酸咖啡因治疗早产儿呼吸暂停及预防支气管肺发育不良的效果[J].医学信息,2020,33(02):142.[doi:10.3969/j.issn.1006-1959.2020.02.042]
　SHA Chun-na,ZHANG Hai-hong.Effect of Caffeine Citrate on Apnea and Prevention of Bronchopulmonary Dysplasia in Preterm Infants[J].Medical Information,2020,33(23):142.[doi:10.3969/j.issn.1006-1959.2020.02.042]
[12]张艳妮,李世玲,邓 春.动脉导管未闭与支气管肺发育不良发生风险相关性的Meta分析[J].医学信息,2023,36(18):33.[doi:10.3969/j.issn.1006-1959.2023.18.006]
　ZHANG Yan-ni,LI Shi-ling,DENG Chun.Meta-analysis of the Correlation Between Patent Ductus Arteriosus and the Risk of Bronchopulmonary Dysplasia[J].Medical Information,2023,36(23):33.[doi:10.3969/j.issn.1006-1959.2023.18.006]

更新日期/Last Update: 1900-01-01